Long-Term Hearing Outcomes Following Stereotactic Radiosurgery in Vestibular Schwannoma Patients—A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Long-Term Hearing Outcomes Following Stereotactic Radiosurgery in Vestibular Schwannoma Patients—A Retrospective Cohort Study

Published:2018-09-20 Issue:4 Volume:85 Page:550-559
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:Neurosurg.

Author:

Santa Maria Peter L,Shi Yangyang,Gurgel Richard K,Corrales C Eduardo,Soltys Scott G,Santa Maria Chloe,Murray Kevin,Chang Steven D,Blevins Nikolas H,Gibbs Iris C,Jackler Robert K

Funder

NCI Cancer Center Support

NIH

NCRR

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Surgery

Link

http://academic.oup.com/neurosurgery/article-pdf/85/4/550/33524269/nyy407.pdf

Reference43 articles.

1. Experience of multidisciplinary team meetings in vestibular schwannoma: A preliminary report;Daveau;Eur Arch Otorhinolaryngol,2015

2. The art of management decision making: from intuition to evidence-based medicine;Sheth;Otolaryngol Clin North Am,2012

3. Mapping clinical outcomes expectations to treatment decisions: an application to vestibular schwannoma management;Cheung;Otol Neurotol,2010

4. Guiding patients through the choices for treating vestibular schwannomas: Balancing options and ensuring informed consent;Backous;Neurosurg Clin N Am,2008

5. Stereotactic radiation therapy and radiosurgery;Ostertag;Stereotact Funct Neurosurg,1994

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hearing Improvement after Radiation Therapy for a Facial Nerve Schwannoma: Report of a Case and Review of Literature;Journal of Neurological Surgery Reports;2024-07

2. Losartan May Not Prevent Vestibular Schwannoma Growth or Related Hearing Loss During Observation;Otology & Neurotology;2024-07

3. Role of lncRNAs in brain tumors;Gene Reports;2024-06

4. Vestibular Schwannoma;Hypofractionated and Stereotactic Radiation Therapy;2024

5. Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis;Current Oncology Reports;2023-10-31